| HOME >> BIOLOGY >> TECHNOLOGY |
BMP Sunstone's management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenses and expenditures that may not be indicative of our core business operating results. BMP Sunstone believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing BMP Sunstone's performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to BMP Sunstone's historical performance and our competitors' operating results. BMP Sunstone believes that these non-GAAP measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision-making.
About BMP Sunstone Corporation
BMP Sunstone Corporation is a specialty pharmaceutical company that is
building a proprietary portfolio of branded pharmaceutical and healthcare
products in China. Currently this portfolio includes eight products under
exclusive multi-year licenses for China, primarily focused on women's
health and pediatrics. The Company also owns Sunstone Pharmaceutical Co.
Ltd., which manufactures leading pediatric and women's health products,
including two of China's most recognized brands, "Hao Wawa" and "Confort,"
sold through approximately 50,000 pharmacies in China. The Company also
provides pharmaceutical distribution services through its subsidiaries in
Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals
Corp. The Company has its main office in Beijing, with a US office in
Plymouth Meeting, PA. For more information, please visit
| SOURCE BMP Sunstone Corporation Copyright©2008 PR Newswire. All rights reserved |